Join our community of traders FOR FREE!

  • Learn
  • Improve yourself
  • Get Rewards
Learn More

Watermark Lodging Trust Inc said last Friday that it had entered into a definitive agreement with private real estate funds managed by Brookfield, under which Brookfield will purchase all of the outstanding shares of common stock of Watermark for $6.768 per Class A share and $6.699 per Class T share.

The total value of the all-cash transaction is estimated at $3.8 billion, including the assumption of debt and preferred equity.

Watermark’s Board of Directors has unanimously approved the proposed transaction, which is expected to be finalized during the fourth quarter of this year.

The Watermark portfolio includes high-quality lodging assets consisting of 25 properties with a total of over 8,100 rooms. Those luxury and upper upscale assets are located in drive-to leisure destinations and gateway urban cities across 14 states.

“We are very pleased to reach this agreement with Brookfield, as it achieves our longer-term objective of a liquidity event, while providing our stockholders with an immediate and certain cash value,” Michael Medzigian, Chairman and Chief Executive Officer of Watermark, said in a press release.

“The transaction’s premium to our most recently published Net Asset Values per share represents the strong execution of our entire team who have demonstrated the ability to find innovative solutions to address the challenges brought on by the COVID-19 pandemic. I would like to thank the members of our Watermark team, across all functions, for their dedication and hard work over the past several years,” the CEO added.

Morgan Stanley & Co. LLC was the exclusive financial advisor to Watermark, Hodges Ward Elliott served as real estate advisor, while Clifford Chance US LLP and Paul Hastings LLP acted as legal counsel.

Meanwhile, Fried Frank Harris Shriver & Jacobson LLP acted as legal counsel to Brookfield Asset Management, while Citigroup, Bank of America, JP Morgan and Wells Fargo served as financial advisors.

TradingPedia.com is a financial media specialized in providing daily news and education covering Forex, equities and commodities. Our academies for traders cover Forex, Price Action and Social Trading.

Related News

  • Okta Exceeds Q4 Forecasts, Shares Surge 15% in Pre-Market TradingOkta Exceeds Q4 Forecasts, Shares Surge 15% in Pre-Market Trading Key momentsOkta's shares experienced a substantial 15.25% pre-market increase, reaching $100.45, driven by the company's Q4 fiscal 2025 results. Okta reported adjusted EPS and revenue that exceeded consensus estimates, and provided […]
  • Apple left behind in the TV conquer raceApple left behind in the TV conquer race We have been all waiting for the moment when television will become what we call “revolutionary”. Probably all gadget fans eagerly expect things such as screen personalization, voice recognition and great choice of TV programs, shows and other […]
  • Oil Pulls Back as US-Iran Hormuz Deal Eases Supply FearOil Pulls Back as US-Iran Hormuz Deal Eases Supply Fear Key Moments Brent crude futures for November delivery declined 0.4% to $106.15 per barrel, while U.S. WTI fell 1.1% to $93.62 per barrel as of 04:02 ET (08:02 GMT). Prices had jumped as much as 5% in the prior session after […]
  • Outlook for AUD/USD during the upcoming weekOutlook for AUD/USD during the upcoming week Australian dollar extended daily losses against its US counterpart on trading Friday and registered a weekly loss for the first time in four weeks, after prices of iron ore, Australia’s largest export, dropped.Having fallen to a daily low […]
  • BTC/USD Price Forecast, Aug 26, 2020 – Fibonacci Retracement In Play!BTC/USD Price Forecast, Aug 26, 2020 – Fibonacci Retracement In Play! { "@context": "http://schema.org", "@type": "VideoObject", "name": "BTC/USD Price Forecast, Aug 26, 2020 - Fibonacci Retracement In Play!", "description": "The BTC/USD prices are taking a bullish turn after […]
  • AbbVie appoints new Chief Executive OfficerAbbVie appoints new Chief Executive Officer AbbVie Inc (NYSE: ABBV) said on Tuesday that its Board of Directors had appointed Robert A. Michael, the company’s current President and Chief Operating Officer, to the role of Chief Executive Officer.Michael is to succeed Richard A. […]